Over the past several decades, the semiconductor industry has experienced sustained growth. Early expansion was driven by the ...
If you're a woman newly diagnosed with breast cancer, treatment can feel ... well, scary. Will chemotherapy work? Or will it ...
A new "tumor-on-a-chip" model is giving scientists a live look at how pancreatic cancer can recruit the body's own immune ...
The global biomarkers market is projected to grow to $112.1b by 2031, from $67.95b in 2026, due to expanding use in drug ...
Modern wireless communication systems prefer higher frequencies to meet the growing demand for faster data transfer. The ...
Researchers from the Cancer Science Institute of Singapore (CSI Singapore) at NUS have developed a new method that allows ...
An international team, including the University of Tokyo, has created a sensor inspired by the lateral line in fish—their ...
Unity, a microreactor from Houston-based Deployable Energy, is the latest of the three to reach criticality as part of a ...
Much like radio operators being encouraged to use the least possible amount of power to make a contact, chemists have a ...
A successful partnership between Pitt’s BioForge subsidiary and a New York-based biotech startup has kept the latter in ...
Terrestrial Bio has dosed the first patients in a Phase I clinical trial evaluating its patch that delivers GLP-1 therapeutic ...
Background Wolf–Hirschhorn syndrome (WHS) is a contiguous gene deletion syndrome involving variable size deletions of the 4p16.3 region. Seizures are frequently, but not always, associated with WHS.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results